Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Reexamination Certificate
2003-10-06
2010-02-02
Azpuru, Carlos A (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
C424S465000
Reexamination Certificate
active
07655256
ABSTRACT:
The present invention provides a pharmaceutical that includes, in combination, a resinate and an aversive agent. The resinate includes an ion exchange resin and an drug. The drug is a controlled substance. In variants of the invention, both the aversive agent and the controlled substance are loaded onto the ion exchange resin; the aversive agent is loaded onto the ion exchange resin, and the controlled substance is not loaded onto the ion exchange resin; the controlled substance is loaded onto the ion exchange resin, and the aversive agent is not loaded onto the ion exchange resin; or, the controlled substance is loaded onto a first ion exchange resin, and the aversive agent is loaded onto an ion exchange resin different from the first ion exchange resin.
REFERENCES:
patent: 3268577 (1966-08-01), Hay
patent: 3773955 (1973-11-01), Pachter at al.
patent: 3966940 (1976-06-01), Pachter et al.
patent: 3980766 (1976-09-01), Shaw et al.
patent: 4070494 (1978-01-01), Hoffmeister et al.
patent: 4457933 (1984-07-01), Gordon et al.
patent: 4529583 (1985-07-01), Porter
patent: 4599342 (1986-07-01), LaHann
patent: 5334378 (1994-08-01), Mitani et al.
patent: 6228863 (2001-05-01), Palermo
patent: 7332182 (2008-02-01), Sackler
patent: 0 709 098 (1996-05-01), None
patent: 862 242 (1961-03-01), None
patent: 2 331 702 (1999-06-01), None
patent: 2 358 585 (2001-08-01), None
patent: 05279245 (1993-10-01), None
patent: 90 / 04965 (1990-05-01), None
patent: 91/07950 (1991-06-01), None
patent: 95/20947 (1995-08-01), None
patent: 00/33835 (2000-06-01), None
patent: 01/08661 (2001-02-01), None
patent: 02/094254 (2002-11-01), None
patent: 03 / 013476 (2003-02-01), None
Page, Henry A.S., “Bitrex—a bitter solution to safety,”Chemistry and Industry(London) Nov. 21, 1988, pp. 721-723.
Smith, R.L.Ecology and Field Biology, third edition, published by Harper and Row, 1980 p. 562.
Porter, Stuart C., “Coating of Pharmaceutical Dosage Forms,” Chapter 46 ofRemington: The Science and Practice of Pharmacy, 20th edition, by Alfonso R. Gennary, published by Lippincott Williams & Wilkins, 2003.
Glenn, M., “Hillbilly Heroin,”Houston Chronicle, Aug. 7, 2001.
Rudnic, M.R. et. al, “Oral Solid Dosage Forms,” Chapter 45 ofRemington: The Science and Practice of Pharmacy, 20th edition, by Alfonso R. Gennary, published by Lippincott Williams & Wilkins, 2003.
Kalb, C., “Playing With Pain Killers,”Newsweek, Apr. 9, 2001, p. 44.
Rosenberg, D., “How One Town Got Hooked,”Newsweek, Apr. 9, 2001, p. 48.
Merck Index, 13th edition, 2001, published by Merck & Co., Whitehouse Station, NJ, USA, p. 296.
Azpuru Carlos A
Cottingham Tifani M.
Rohm and Haas Company
LandOfFree
Pharmaceutical formulation including a resinate and an... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical formulation including a resinate and an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulation including a resinate and an... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4218584